Regeneron Pharmaceuticals Profit Margin 2006-2021 | REGN
Current and historical gross margin, operating margin and net profit margin for Regeneron Pharmaceuticals (REGN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Regeneron Pharmaceuticals net profit margin as of June 30, 2021 is 50.11%.
|Regeneron Pharmaceuticals Annual Profit Margins
|Regeneron Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.